Chapters

Transcript

Video

Bladder Cancer Advances

Dana-Farber's Guru Sonpavde, MD discusses two studies with promising results. One study looks at pre-operative therapy, the other study compares an antibody-drug conjugate to chemotherapy in urothelial carcinoma.


Published

April 5, 2021

Created by

Dana-Farber

Related Presenters

Guru P. Sonpavde, MD

Guru P. Sonpavde, MD

Medical Oncology

Guru P. Sonpavde, MD is the Bladder Cancer Director at Dana Farber Cancer Institute.

View Profile